Oncotarget

Keyphrases

Publications

volume 14, 2023

Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M Martin, Athene Lane, Lucy Hackshaw-McGeagh, Claire Perks
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells. Oncotarget 14 (2023)
Leo I Gordon, Reem Karmali, Jason B Kaplan, Rakesh Popat, Howard A Burris, Silvia Ferrari, Sumit Madan, Manish R Patel, Giuseppe Gritti, Dima El-Sharkawi, F Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659). Oncotarget 14 (2023)
Munemasa Nagao, Akihisa Fukuda, Hiroshi Seno
The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system. Oncotarget 14 (2023)
Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima
Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer. Oncotarget 14 (2023)
Jessica T Gomes, Ana Márcia V Wanzeler, Sergio M A Júnior, Rosa Helena F Chaves Soares, Carolina P de Oliveira, Emanuelle de M Rodrigues, Bruno M Soares, Diego D F A Alcantara, Rommel M R Burbano, Fabrício M Tuji
The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option. Oncotarget 14 (2023)
Fiorella Vanderhoeven, Analía Lourdes Redondo, Ana Laura Martinez, Laura María Vargas-Roig, Angel Matias Sanchez, Marina Inés Flamini
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells. Oncotarget 14 (2023)
Francesca Cottini, Don Benson
To be or not to be: the role of CD56 in multiple myeloma. Oncotarget 14 (2023)
Leo I Gordon, Reem Karmali, Jason B Kaplan, Rakesh Popat, Howard A Burris, Silvia Ferrari, Sumit Madan, Manish R Patel, Giuseppe Gritti, Dima El-Sharkawi, F Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659). Oncotarget 14 (2023)
Joshua D Bernstock, Sarah Blitz, Kyung-Don Kang, Gregory K Friedman
Intraventricular immunovirotherapy; a translational step forward. Oncotarget 14 (2023)
Joshua D Bernstock, Sarah Blitz, Kyung-Don Kang, Gregory K Friedman
Intraventricular immunovirotherapy; a translational step forward. Oncotarget 14 (2023)
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, Stefanie Krassnig, Margit Gogg-Kamerer, Nadine Gantenbein, Anna M Toeglhofer, Christina Wodlej, Helmut Bergler, Brigitte Pertschy, Stefan Uranitsch, Magdalena Holter, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Christoph Reinhard, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd Lax, Johannes Haybaeck
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6. Oncotarget 14 (2023)
Jessica T Gomes, Ana Márcia V Wanzeler, Sergio M A Júnior, Rosa Helena F Chaves Soares, Carolina P de Oliveira, Emanuelle de M Rodrigues, Bruno M Soares, Diego D F A Alcantara, Rommel M R Burbano, Fabrício M Tuji
The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option. Oncotarget 14 (2023)
Anqi Shao, David M Owens
The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy. Oncotarget 14 (2023)
Munemasa Nagao, Akihisa Fukuda, Hiroshi Seno
The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system. Oncotarget 14 (2023)
Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima
Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer. Oncotarget 14 (2023)
Chengcao Sun, Ming Sang, Shujun Li, Xiaodong Sun, Cuili Yang, Yongyong Xi, Liang Wang, Feng Zhang, Yongyi Bi, Yunfeng Fu, Dejia Li
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 14 (2023)
Wiktoria Blaszczak, Pawel Swietach
Permeability and driving force: why is difficult to control glycolytic flux by blocking lactate transporters? Oncotarget 14 (2023)
Wiktoria Blaszczak, Pawel Swietach
Permeability and driving force: why is difficult to control glycolytic flux by blocking lactate transporters? Oncotarget 14 (2023)
Leo I Gordon, Reem Karmali, Jason B Kaplan, Rakesh Popat, Howard A Burris, Silvia Ferrari, Sumit Madan, Manish R Patel, Giuseppe Gritti, Dima El-Sharkawi, F Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659). Oncotarget 14 (2023)
Christina Kuhn, Myriam Boeschen, Manuel Philip, Torsten Schöneberg, Doreen Thor, Susanne Horn
Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels. Oncotarget 14 (2023)
Jessica T Gomes, Ana Márcia V Wanzeler, Sergio M A Júnior, Rosa Helena F Chaves Soares, Carolina P de Oliveira, Emanuelle de M Rodrigues, Bruno M Soares, Diego D F A Alcantara, Rommel M R Burbano, Fabrício M Tuji
The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option. Oncotarget 14 (2023)
Christina Kuhn, Myriam Boeschen, Manuel Philip, Torsten Schöneberg, Doreen Thor, Susanne Horn
Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels. Oncotarget 14 (2023)
Jessica T Gomes, Ana Márcia V Wanzeler, Sergio M A Júnior, Rosa Helena F Chaves Soares, Carolina P de Oliveira, Emanuelle de M Rodrigues, Bruno M Soares, Diego D F A Alcantara, Rommel M R Burbano, Fabrício M Tuji
The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option. Oncotarget 14 (2023)
Joshua D Bernstock, Sarah Blitz, Kyung-Don Kang, Gregory K Friedman
Intraventricular immunovirotherapy; a translational step forward. Oncotarget 14 (2023)
David King, Xiao Dun Li, Gilberto S Almeida, Colin Kwok, Polly Gravells, Daniel Harrison, Saoirse Burke, Albert Hallsworth, Yann Jamin, Sally George, Simon P Robinson, Christopher J Lord, Evon Poon, Daniel Yeomanson, Louis Chesler, Helen E Bryant
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget 14 (2023)
Md Maksudul Alam, Janmaris Marin Fermin, Mark Knackstedt, Mackenzie J Noonan, Taylor Powell, Landon Goodreau, Emily K Daniel, Xiaohua Rong, Tara Moore-Medlin, Alok R Khandelwal, Cherie-Ann O Nathan
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget 14 (2023)
Xiaofan Li, Cristina Abrahams, Abigail Yu, Millicent Embry, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Trevor Hallam, Mark Lupher, Arturo Molina
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget 14 (2023)
Anqi Shao, David M Owens
The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy. Oncotarget 14 (2023)
Anqi Shao, David M Owens
The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy. Oncotarget 14 (2023)
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, Stefanie Krassnig, Margit Gogg-Kamerer, Nadine Gantenbein, Anna M Toeglhofer, Christina Wodlej, Helmut Bergler, Brigitte Pertschy, Stefan Uranitsch, Magdalena Holter, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Christoph Reinhard, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd Lax, Johannes Haybaeck
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6. Oncotarget 14 (2023)
Francesca Cottini, Don Benson
To be or not to be: the role of CD56 in multiple myeloma. Oncotarget 14 (2023)
Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima
Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer. Oncotarget 14 (2023)
Chengcao Sun, Ming Sang, Shujun Li, Xiaodong Sun, Cuili Yang, Yongyong Xi, Liang Wang, Feng Zhang, Yongyi Bi, Yunfeng Fu, Dejia Li
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 14 (2023)
Md Maksudul Alam, Janmaris Marin Fermin, Mark Knackstedt, Mackenzie J Noonan, Taylor Powell, Landon Goodreau, Emily K Daniel, Xiaohua Rong, Tara Moore-Medlin, Alok R Khandelwal, Cherie-Ann O Nathan
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget 14 (2023)
Munemasa Nagao, Akihisa Fukuda, Hiroshi Seno
The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system. Oncotarget 14 (2023)
Fiorella Vanderhoeven, Analía Lourdes Redondo, Ana Laura Martinez, Laura María Vargas-Roig, Angel Matias Sanchez, Marina Inés Flamini
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells. Oncotarget 14 (2023)
Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M Martin, Athene Lane, Lucy Hackshaw-McGeagh, Claire Perks
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells. Oncotarget 14 (2023)
Wiktoria Blaszczak, Pawel Swietach
Permeability and driving force: why is difficult to control glycolytic flux by blocking lactate transporters? Oncotarget 14 (2023)
Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M Martin, Athene Lane, Lucy Hackshaw-McGeagh, Claire Perks
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells. Oncotarget 14 (2023)
Fiorella Vanderhoeven, Analía Lourdes Redondo, Ana Laura Martinez, Laura María Vargas-Roig, Angel Matias Sanchez, Marina Inés Flamini
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells. Oncotarget 14 (2023)
Francesca Cottini, Don Benson
To be or not to be: the role of CD56 in multiple myeloma. Oncotarget 14 (2023)
Keisuke Taniuchi, Mitsunari Ogasawara
Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Oncotarget 14 (2023)
Xiaofan Li, Cristina Abrahams, Abigail Yu, Millicent Embry, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Trevor Hallam, Mark Lupher, Arturo Molina
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget 14 (2023)
David King, Xiao Dun Li, Gilberto S Almeida, Colin Kwok, Polly Gravells, Daniel Harrison, Saoirse Burke, Albert Hallsworth, Yann Jamin, Sally George, Simon P Robinson, Christopher J Lord, Evon Poon, Daniel Yeomanson, Louis Chesler, Helen E Bryant
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget 14 (2023)
Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Neelam Shirsat, Sridhar Epari, Girish Chinnaswamy, Tejpal Gupta
WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Oncotarget 14 (2023)
Martin Chevarin, Diana Alcantara, Juliette Albuisson, Marie-Agnès Collonge-Rame, Céline Populaire, Zohair Selmani, Amandine Baurand, Caroline Sawka, Geoffrey Bertolone, Patrick Callier, Yannis Duffourd, Philippe Jonveaux, Yves-Jean Bignon, Isabelle Coupier, François Cornelis, Christophe Cordier, Monique Mozelle-Nivoix, Jean-Baptiste Rivière, Paul Kuentz, Christel Thauvin, Romain Boidot, François Ghiringhelli, Marc O'Driscoll, Laurence Faivre, Sophie Nambot
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles. Oncotarget 14 (2023)
Chengcao Sun, Ming Sang, Shujun Li, Xiaodong Sun, Cuili Yang, Yongyong Xi, Liang Wang, Feng Zhang, Yongyi Bi, Yunfeng Fu, Dejia Li
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 14 (2023)
Xiaofan Li, Cristina Abrahams, Abigail Yu, Millicent Embry, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Trevor Hallam, Mark Lupher, Arturo Molina
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget 14 (2023)
Christina Kuhn, Myriam Boeschen, Manuel Philip, Torsten Schöneberg, Doreen Thor, Susanne Horn
Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels. Oncotarget 14 (2023)
David King, Xiao Dun Li, Gilberto S Almeida, Colin Kwok, Polly Gravells, Daniel Harrison, Saoirse Burke, Albert Hallsworth, Yann Jamin, Sally George, Simon P Robinson, Christopher J Lord, Evon Poon, Daniel Yeomanson, Louis Chesler, Helen E Bryant
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget 14 (2023)